Results 6,801-6,820 of 24,338 for speaker:Jerry Buttimer
- Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)
Jerry Buttimer: Can I interrupt the Deputy? The Chair has no role in that, as the Deputy is aware.
- Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)
Jerry Buttimer: That matter is addressed.
- Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)
Jerry Buttimer: We will not have a discussion on that now. That matter is independent of us. It is a procedural matter.
- Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)
Jerry Buttimer: It is a procedural matter, Deputy Ó Caoláin, and as you are aware-----
- Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)
Jerry Buttimer: Unfortunately, Deputy Ó Caoláin, it is beyond the remit of the Chair. It is an interpretation given by the Bills Office. We have communicated to you on what we received from the Bills Office. The Chair has no involvement in matters regarding amendments, as the Deputy knows quite well being a long-term parliamentarian. That matter is concluded.
- Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)
Jerry Buttimer: I am not being discourteous to the Deputy; it is just that we have no say in the matter.
- Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)
Jerry Buttimer: For the benefit of the meeting and to clarify, lest Deputy Ó Caoláin thinks the Chair is not sympathetic or supportive of what he has been saying, as Chairman of the committee I have been advised that the Bill provides for the introduction of a system of generic substitution and referenced pricing of interchangeable generic medicines. Amendments Nos. 2 to 5, inclusive, in the names...
- Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)
Jerry Buttimer: I reiterate the point I made to Deputy Ó Caoláin. I am very aware of the issues and I have met members of Epilepsy Ireland. I have had e-mails from members of the public who are directly affected by what is happening, but I cannot change Standing Orders no more than the Deputy can, and he is a long-standing parliamentarian also. Unfortunately, the Chair's hands are tied in terms...
- Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)
Jerry Buttimer: Yes.
- Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)
Jerry Buttimer: In case members did not get it, the Irish Medicines Board forwarded a response which was late coming to the committee. When we received it we forwarded it to members.
- Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)
Jerry Buttimer: No. Amendments Nos. 1, 8 and 10 will be discussed together but they are not to this section. We are on section 3.
- Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)
Jerry Buttimer: Section 2 has been agreed.
- Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)
Jerry Buttimer: Will there be a sufficient lead-in time after the passing of the legislation and will it be adequate for the patient and the pharmacist? Can we allay the fears being expressed to us by pharmacists and patients in the context of communicating the changes to the public and the pharmacists?
- Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)
Jerry Buttimer: We will deal with that under section 5.
- Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)
Jerry Buttimer: We will wait until section 5. Deputy Kelleher's question pertains to section 4.
- Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)
Jerry Buttimer: The big worry Deputies and patients have is about communication with older people who may not have Internet access or who do not read the notices in pharmacies. How do we plan to communicate with such people?
- Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)
Jerry Buttimer: I am not being ageist in that.
- Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)
Jerry Buttimer: We are on section 4.
- Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)
Jerry Buttimer: If we deal with section 4 we can come back to the Deputy's point later.
- Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)
Jerry Buttimer: We are debating section 4.